Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)

被引：0
|
作者：
Aleksandra Butrym
Ewa Lech-Maranda
Elżbieta Patkowska
Beata Kumiega
Maria Bieniaszewska
Andrzej Mital
Krzysztof Madry
Tigran Torosian
Ryszard Wichary
Justyna Rybka
Krzysztof Warzocha
Grzegorz Mazur
机构：
[1] Wroclaw Medical University,Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation
[2] Wroclaw Medical University,Department of Physiology
[3] Institute of Hematology and Transfusion Medicine,Department of Hematology
[4] Institute of Hematology and Transfusion Medicine,Centre of Postgraduate Medical Education, Warsaw
[5] Carpathian Oncology Centre,Department of Oncological Hematology
[6] Medical University of Gdansk,Department of Hematology and Transplantology
[7] Warsaw Medical University,Department of Hematology
[8] Silesian Medical University,Department of Hematology and Bone Marrow Transplantation
[9] Occupational Diseases and Hypertension,Department of Internal Medicine
[10] Wroclaw Medical University,Department of Hematology
[11] Institute of Hematology and Transfusion Medicine,undefined
来源：
BMC Cancer | / 15卷
关键词：
Myelodysplastic syndrome; del(5q); Lenalidomide; Transfusion independence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
    Butrym, Aleksandra
    Lech-Maranda, Ewa
    Patkowska, Elzbieta
    Kumiega, Beata
    Bieniaszewska, Maria
    Mital, Andrzej
    Madry, Krzysztof
    Torosian, Tigran
    Wichary, Ryszard
    Rybka, Justyna
    Warzocha, Krzysztof
    Mazur, Grzegorz
    [J]. BMC CANCER, 2015, 15
  • [2] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [3] Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion-The GFM experience
    Le Bras, Fabien
    Sebert, Marie
    Kelaidi, Charikleia
    Lamy, Thierry
    Dreyfus, Francois
    Delaunay, Jacques
    Banos, Anne
    Blanc, Michel
    Vey, Norbert
    Schmidt, Aline
    Visanica, Sorin
    Eclache, Virginie
    Turlure, Pascal
    Beyne-Rauzy, Odile
    Guerci, Agnes
    Delmer, Alain
    de Botton, Stephane
    Rea, Delphine
    Fenaux, Pierre
    Ades, Lionel
    [J]. LEUKEMIA RESEARCH, 2011, 35 (11) : 1444 - 1448
  • [4] Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
    Giagounidis, Aristoteles A. N.
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 312 - 322
  • [5] Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity
    Hong, Junshik
    Lee, Yoo Jin
    Bae, Sung Hwa
    Yi, Jun Ho
    Park, Sungwoo
    Chang, Myung Hee
    Park, Young Hoon
    Hyun, Shin Young
    Chung, Joo-Seop
    Jang, Ji Eun
    Jung, Joo Young
    Jeon, So-Yeon
    Song, Seo-Young
    Kim, Hawk
    Kim, Dae Sik
    Kim, Sung-Hyun
    Kim, Min Kyoung
    Han, Sang Hoon
    Park, Seonyang
    Kim, Yoo-Jin
    Lee, Je-Hwan
    [J]. BLOOD RESEARCH, 2021, 56 (02) : 102 - 107
  • [6] Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients
    Martinez-Hoyer, Sergio
    Docking, Rod
    Chan, Simon
    Jadersten, Martin
    Parker, Jeremy
    Karsan, Aly
    [J]. BLOOD, 2015, 126 (23)
  • [7] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    [J]. SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
  • [8] Treatment of myelodysplastic syndromes with del 5q before the lenalidomide era:: The GFM experience.
    Kelaidi, Charikleia
    Park, Sophie
    Brechignac, Sabine
    Mannone, Lionel
    Vey, Norbert
    Dombret, Herve
    Aljassem, Lina
    Starnatoullas, Aspasia
    Ades, Lionel
    Giraudier, Setphane
    de Botton, Stephane
    Mahe, Beatrice
    Lepelley, Pascale
    Picard, Fracoise
    Leroux, Genevieve
    Daniel, Marie-Threrese
    Bouscary, Didier
    Dreyfus, Francois
    Fenaux, Pierre
    [J]. BLOOD, 2006, 108 (11) : 757A - 757A
  • [9] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome With Isolated Del(5q) With Lenalidomide, Bortezomib, and Dexamethasone
    Washington, Nyomi R.
    Shippey, Eugen A.
    Osswald, Michael
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [10] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome with Isolated Del(5q) with Lenalidomide, Bortezomib, and Dexamethasone
    Washington, Nyomi
    Shippey, Eugen A., III
    Osswald, Michael B.
    [J]. BLOOD, 2020, 136
12345